Panel Discussion: Indication Expansion to Autoimmune & Prevalent Disorders for Approved Complement Inhibitors
Time: 2:30 pm
day: Conference Day One
Details:
- Discussing lessons learned from approved complement inhibitors and the back-translation necessary to pivot a drug to new indications
- Developing second generation inhibitors to improve safety and activity
